NRC Challenge Program: Disruptive Technology Solutions for Cell and Gene Therapy
Monday, November 4, 2019
Shaw Centre Canada Hall 2 and 3
The Disruptive Technology Solutions for Cell and Gene Therapy Program will unify the value chain for engineered cell and gene therapies across the continuum from discovery to commercialization. Through collaborative partnerships with key stakeholders, it will advance a unique initiative to bring disruptive solutions to the design, development and delivery of cell and gene therapy to patients in Canada.
In doing so, the NRC will coordinate a national effort, in collaboration with academic facilities, research centres and networks, clinicians, hospital centres and others, to increase the affordability and accessibility of these ground-breaking technologies to enable a national ecosystem for health innovation in the area of cell and gene therapies.